These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33019888)

  • 1. A randomized control trial of intensive aphasia therapy after acute stroke: The Very Early Rehabilitation for SpEech (VERSE) study.
    Godecke E; Armstrong E; Rai T; Ciccone N; Rose ML; Middleton S; Whitworth A; Holland A; Ellery F; Hankey GJ; Cadilhac DA; Bernhardt J;
    Int J Stroke; 2021 Jul; 16(5):556-572. PubMed ID: 33019888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of very early rehabilitation in speech after stroke.
    Godecke E; Armstrong EA; Rai T; Middleton S; Ciccone N; Whitworth A; Rose M; Holland A; Ellery F; Hankey GJ; Cadilhac DA; Bernhardt J
    Int J Stroke; 2016 Jul; 11(5):586-92. PubMed ID: 27151156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment fidelity monitoring, reporting and findings in a complex aphasia intervention trial: a substudy of the Very Early Rehabilitation in SpEech (VERSE) trial.
    Godecke E; Brogan E; Ciccone N; Rose ML; Armstrong E; Whitworth A; Ellery F; Holland A; Middleton S; Rai T; Hankey GJ; Cadilhac D; Bernhardt J
    Trials; 2022 Jun; 23(1):501. PubMed ID: 35710437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial.
    Palmer R; Dimairo M; Cooper C; Enderby P; Brady M; Bowen A; Latimer N; Julious S; Cross E; Alshreef A; Harrison M; Bradley E; Witts H; Chater T
    Lancet Neurol; 2019 Sep; 18(9):821-833. PubMed ID: 31397288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of the Very Early Rehabilitation in SpEech (VERSE) intervention.
    Kim J; Sookram G; Godecke E; Brogan E; Armstrong E; Ellery F; Rai T; Rose ML; Ciccone N; Middleton S; Holland A; Hankey GJ; Bernhardt J; Cadilhac DA
    Top Stroke Rehabil; 2024 Mar; 31(2):157-166. PubMed ID: 37415422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical analysis plan for the COMPARE trial: a 3-arm randomised controlled trial comparing the effectiveness of Constraint-induced Aphasia Therapy Plus and Multi-modality Aphasia Therapy to usual care in chronic post-stroke aphasia (COMPARE).
    Rose ML; Rai T; Copland D; Nickels L; Togher L; Meinzer M; Godecke E; Kim J; Cadilhac DA; Hurley M; Wilcox C; Carragher M
    Trials; 2021 Apr; 22(1):303. PubMed ID: 33892764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting.
    Breitenstein C; Grewe T; Flöel A; Ziegler W; Springer L; Martus P; Huber W; Willmes K; Ringelstein EB; Haeusler KG; Abel S; Glindemann R; Domahs F; Regenbrecht F; Schlenck KJ; Thomas M; Obrig H; de Langen E; Rocker R; Wigbers F; Rühmkorf C; Hempen I; List J; Baumgaertner A;
    Lancet; 2017 Apr; 389(10078):1528-1538. PubMed ID: 28256356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of speech language therapy either alone or with add-on computer-based language therapy software (Malayalam version) for early post stroke aphasia: A feasibility study.
    Kesav P; Vrinda SL; Sukumaran S; Sarma PS; Sylaja PN
    J Neurol Sci; 2017 Sep; 380():137-141. PubMed ID: 28870554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical analysis plan (SAP) for the Very Early Rehabilitation in Speech (VERSE) after stroke trial: an international 3-arm clinical trial to determine the effectiveness of early, intensive, prescribed, direct aphasia therapy.
    Godecke E; Rai T; Cadilhac DA; Armstrong E; Middleton S; Ciccone N; Whitworth A; Rose ML; Holland A; Ellery F; Hankey GJ; Bernhardt J;
    Int J Stroke; 2018 Oct; 13(8):863-880. PubMed ID: 30270762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of aphasia therapy outcomes before and after a Very Early Rehabilitation programme following stroke.
    Godecke E; Ciccone NA; Granger AS; Rai T; West D; Cream A; Cartwright J; Hankey GJ
    Int J Lang Commun Disord; 2014; 49(2):149-61. PubMed ID: 24588906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability, feasibility and preliminary efficacy of low-moderate intensity Constraint Induced Aphasia Therapy and Multi-Modality Aphasia Therapy in chronic aphasia after stroke.
    Pierce JE; OHalloran R; Togher L; Nickels L; Copland D; Godecke E; Meinzer M; Rai T; Cadilhac DA; Kim J; Hurley M; Foster A; Carragher M; Wilcox C; Steel G; Rose ML
    Top Stroke Rehabil; 2024 Jan; 31(1):44-56. PubMed ID: 37036031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FCET2EC (From controlled experimental trial to = 2 everyday communication): How effective is intensive integrative therapy for stroke-induced chronic aphasia under routine clinical conditions? A study protocol for a randomized controlled trial.
    Baumgaertner A; Grewe T; Ziegler W; Floel A; Springer L; Martus P; Breitenstein C
    Trials; 2013 Sep; 14():308. PubMed ID: 24059983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constraint-induced or multi-modal personalized aphasia rehabilitation (COMPARE): A randomized controlled trial for stroke-related chronic aphasia.
    Rose ML; Copland D; Nickels L; Togher L; Meinzer M; Rai T; Cadilhac DA; Kim J; Foster A; Carragher M; Hurley M; Godecke E
    Int J Stroke; 2019 Dec; 14(9):972-976. PubMed ID: 31496440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very early poststroke aphasia therapy: a pilot randomized controlled efficacy trial.
    Godecke E; Hird K; Lalor EE; Rai T; Phillips MR
    Int J Stroke; 2012 Dec; 7(8):635-44. PubMed ID: 21978210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of enhanced communication therapy in the first four months after stroke for aphasia and dysarthria: a randomised controlled trial.
    Bowen A; Hesketh A; Patchick E; Young A; Davies L; Vail A; Long AF; Watkins C; Wilkinson M; Pearl G; Ralph MA; Tyrrell P
    BMJ; 2012 Jul; 345():e4407. PubMed ID: 22797843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of the COMPARE trial of Constraint-induced or Multimodality Aphasia Therapy compared with usual care in chronic post-stroke aphasia.
    Rose ML; Nickels L; Copland D; Togher L; Godecke E; Meinzer M; Rai T; Cadilhac DA; Kim J; Hurley M; Foster A; Carragher M; Wilcox C; Pierce JE; Steel G
    J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):573-581. PubMed ID: 35396340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amount of therapy matters in very early aphasia rehabilitation after stroke: a clinical prognostic model.
    Godecke E; Rai T; Ciccone N; Armstrong E; Granger A; Hankey GJ
    Semin Speech Lang; 2013 Aug; 34(3):129-41. PubMed ID: 24166188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, rater-blinded, parallel trial of intensive speech therapy in sub-acute post-stroke aphasia: the SP-I-R-IT study.
    Martins IP; Leal G; Fonseca I; Farrajota L; Aguiar M; Fonseca J; Lauterbach M; Gonçalves L; Cary MC; Ferreira JJ; Ferro JM
    Int J Lang Commun Disord; 2013; 48(4):421-31. PubMed ID: 23889837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized, parallel group, controlled study of the effect of intensity of speech and language therapy on early recovery from poststroke aphasia.
    Bakheit AM; Shaw S; Barrett L; Wood J; Carrington S; Griffiths S; Searle K; Koutsi F
    Clin Rehabil; 2007 Oct; 21(10):885-94. PubMed ID: 17981847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of augmented speech-language therapy delivered by telerehabilitation on poststroke aphasia-a pilot randomized controlled trial.
    Øra HP; Kirmess M; Brady MC; Partee I; Hognestad RB; Johannessen BB; Thommessen B; Becker F
    Clin Rehabil; 2020 Mar; 34(3):369-381. PubMed ID: 31903800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.